Internal medicine, Endocrinology, Ovarian cancer, Metastasis and Cancer stem cell are his primary areas of study. Internal medicine is often connected to In vitro in his work. Jock K. Findlay combines subjects such as Paracrine signalling and Folliculogenesis with his study of Endocrinology.
His biological study spans a wide range of topics, including Epithelial–mesenchymal transition and Cancer research. The Epithelial–mesenchymal transition study combines topics in areas such as Stem cell and Oncology. His study explores the link between Metastasis and topics such as Chemotherapy that cross with problems in Immunophenotyping.
Jock K. Findlay mainly investigates Internal medicine, Endocrinology, Folliculogenesis, Ovary and Cell biology. As part of one scientific family, Jock K. Findlay deals mainly with the area of Internal medicine, narrowing it down to issues related to the Follicular fluid, and often Ovariectomized rat. All of his Endocrinology and Follicle-stimulating hormone, Follicular phase, Ovulation, Ovarian follicle and Estrous cycle investigations are sub-components of the entire Endocrinology study.
His Folliculogenesis research is multidisciplinary, relying on both Follicle, Andrology, Oocyte, Oogenesis and Reproductive technology. The concepts of his Ovary study are interwoven with issues in Estrogen and Germ cell. His study looks at the relationship between Cell biology and topics such as Endometrium, which overlap with Blastocyst and Menstrual cycle.
The scientist’s investigation covers issues in Cancer stem cell, Ovarian cancer, Cancer research, Internal medicine and Metastasis. His Cancer stem cell study integrates concerns from other disciplines, such as Ovarian carcinoma, Epithelial–mesenchymal transition, Embryonic stem cell and Transplantation. His study in Ovarian cancer is interdisciplinary in nature, drawing from both In vivo and Paclitaxel, Chemotherapy, Cisplatin.
His Cancer research study incorporates themes from Cell cycle and Pathology. His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. He works mostly in the field of Endocrinology, limiting it down to topics relating to Cell biology and, in certain cases, In vitro.
Jock K. Findlay mainly focuses on Cancer stem cell, Ovarian cancer, Metastasis, Cancer research and Stem cell. Jock K. Findlay regularly links together related areas like Ovarian carcinoma in his Cancer stem cell studies. His Ovarian carcinoma research is multidisciplinary, incorporating perspectives in Tumor progression and Stem cell marker.
His Metastasis study combines topics from a wide range of disciplines, such as Paclitaxel and Chemotherapy. Jock K. Findlay has researched Stem cell in several fields, including Epithelial–mesenchymal transition, Systemic administration, Oncology and After treatment, Internal medicine. His Apoptosis research incorporates themes from Endocrinology and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure
Peter Lutjen;Alan Trounson;John Leeton;Jock Findlay.
An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis.
Jock K. Findlay.
Biology of Reproduction (1993)
TGF-β superfamily expression and actions in the endometrium and placenta
Rebecca L Jones;Rebecca L Jones;Chelsea Stoikos;Jock K Findlay;Lois A Salamonsen.
Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid.
R G Forage;J M Ring;R W Brown;B V McInerney.
Proceedings of the National Academy of Sciences of the United States of America (1986)
A model for follicle selection and the determination of ovulation rate in the ewe
RJ Scaramuzzi;NR Adams;DT Baird;BK Campbell.
Reproduction, Fertility and Development (1993)
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
M Colomiere;A C Ward;C Riley;M K Trenerry.
British Journal of Cancer (2009)
Angiogenesis in reproductive tissues.
J. K. Findlay.
Journal of Endocrinology (1986)
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.
Nuzhat Ahmed;Khalid Abubaker;Jock Findlay;Jock Findlay;Jock Findlay;Michael Quinn.
Current Cancer Drug Targets (2010)
An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene.
Kara L. Britt;Ann E. Drummond;Victoria A. Cox;Mitzilee Dyson.
Effects of bovine inhibin, transforming growth factor-β and bovine activin-A on granulosa cell differentiation
Laura A. Hutchinson;Jock K. Findlay;Fiona L. de Vos;David M. Robertson.
Biochemical and Biophysical Research Communications (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: